uniQure N.V. Cash Flow Statement
QURE / Health Care|11 years of annual SEC 10-K data (FY2014-FY2024)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 11 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Operating Cash Flow
-$183M
FY2024
Free Cash Flow
-$186M
FY2024
Capital Expenditures
$3M
Cash used for long-term assets
Dividends Paid
N/A
FY2024
uniQure N.V. used $183M in operating cash flow and negative free cash flow of $186M in FY2024.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Negative shareholders equity: Liabilities exceed assets
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$239.6M | -$308.5M | -$126.8M | $329.6M | -$125.0M | -$124.2M | -$83.3M | -$79.3M | -$73.4M | -$82.1M | - |
| Depreciation & Amortization | $10.1M | $10.3M | $8.2M | $6.1M | $10.6M | $6.7M | $6.5M | $7.5M | - | $4.4M | $2.0M |
| Operating Cash Flow | -$182.7M | -$145.9M | -$145.1M | $288.0M | -$134.8M | -$98.7M | -$76.0M | -$64.3M | -$72.2M | $7.5M | -$36.9M |
| Capital Expenditures | $3.4M | $7.2M | $17.7M | $17.4M | $7.3M | $5.7M | $2.4M | $4.5M | $15.3M | $7.6M | $22.2M |
| Free Cash Flow | -$186.1M | -$153.1M | -$162.7M | $270.5M | -$142.1M | -$104.3M | -$78.4M | -$68.7M | -$87.5M | -$139.0K | -$59.0M |
| FCF Margin | - | - | - | - | - | - | - | -524.4% | -348.5% | -1.3% | - |